ClinicalTrials.Veeva

Menu

Prevention of Corticosteroid-induced Glucose Intolerance

H

Hadassah Medical Center

Status and phase

Unknown
Phase 3

Conditions

Glucose Intolerance

Treatments

Drug: Rosiglitazone

Study type

Interventional

Funder types

Other

Identifiers

NCT00240604
7-29.10.04-HMO-CTIL

Details and patient eligibility

About

Glucose intolerance is frequent and serious complication of corticosteroid therapy. the aim of the study is to examine the hypothesis that co treatment with rosiglitazone can prevent glucose intolerance in patients treated with corticosteroids.

Full description

Glucose intolerance is frequent and serious complication of corticosteroid therapy. the aim of the study is to examine the hypothesis that co treatment with rosiglitazone can prevent glucose intolerance in patients treated with corticosteroids.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • corticosteroid treatment

Exclusion criteria

  • congestive heart failure pedal edema

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems